Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+371.8%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+371.8%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
105x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 340.21% |
| Q3 2025 | 9.83% |
| Q2 2025 | -15.65% |
| Q1 2025 | 14.68% |
| Q4 2024 | -7.51% |
| Q3 2024 | 13.80% |
| Q2 2024 | -22.86% |
| Q1 2024 | 17.20% |
| Q4 2023 | 23.98% |
| Q3 2023 | 14.65% |
| Q2 2023 | 10.84% |
| Q1 2023 | 15.38% |
| Q4 2022 | 3.24% |
| Q3 2022 | 5.38% |
| Q2 2022 | -5.93% |
| Q1 2022 | 61.68% |
| Q4 2021 | -220.46% |
| Q3 2021 | 20.31% |
| Q2 2021 | 13.25% |
| Q1 2021 | 31.00% |
| Q4 2020 | -1077.01% |
| Q3 2020 | -146.07% |
| Q2 2020 | 127.27% |
| Q1 2020 | 1.58% |
| Q4 2019 | -8.36% |
| Q3 2019 | -35.09% |
| Q2 2019 | 31.60% |
| Q1 2019 | -3.41% |
| Q4 2018 | -21.48% |
| Q3 2018 | 19.66% |
| Q2 2018 | -64.97% |
| Q1 2018 | -440.35% |
| Q4 2017 | 75.50% |
| Q3 2017 | 9.76% |
| Q2 2017 | 2.38% |
| Q1 2017 | -20.65% |
| Q4 2016 | 0.24% |
| Q3 2016 | -14.01% |
| Q2 2016 | 7.61% |
| Q1 2016 | -41.82% |